Patents by Inventor Joseph McKenna
Joseph McKenna has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240164763Abstract: A self-supporting surgical retractor is provided for retracting soft tissue and anatomy at a spinal surgical site. The retractor includes a tubular base defining an upper rim and a lower rim and a working channel there between the upper and lower rims, in which the base and lower rim are sized and configured to be seated on adjacent vertebral bodies spanning an intervertebral space. At least two elongated legs are provided, each projecting from the upper rim and each including a fixation feature at a free end thereof. Each of the legs has a length sufficient for the fixation feature to be outside the body of a patient when the lower rim is seated on adjacent vertebral bodies of the patient. The retractor is formed of a radio-transparent or radio-lucent material.Type: ApplicationFiled: December 19, 2023Publication date: May 23, 2024Inventors: Nick Sandham, Eddie Hamilton, Jonathan Lloyd Arcos, Christopher Reah, John Sutcliffe, Patrick Joseph McKenna, Obi Agu
-
Patent number: 11844504Abstract: A self-supporting surgical retractor is provided for retracting soft tissue and anatomy at a spinal surgical site. The retractor includes a tubular base defining an upper rim and a lower rim and a working channel there between the upper and lower rims, in which the base and lower rim are sized and configured to be seated on adjacent vertebral bodies spanning an intervertebral space. At least two elongated legs are provided, each projecting from the upper rim and each including a fixation feature at a free end thereof. Each of the legs has a length sufficient for the fixation feature to be outside the body of a patient when the lower rim is seated on adjacent vertebral bodies of the patient. The retractor is formed of a radio-transparent or radio-lucent material.Type: GrantFiled: September 18, 2020Date of Patent: December 19, 2023Assignee: Axis Spine Technologies Ltd.Inventors: Nick Sandham, Eddie Hamilton, Jonathan Lloyd Arcos, Christopher Reah, John Sutcliffe, Patrick Joseph McKenna, Obi Agu
-
Publication number: 20230403255Abstract: Various embodiments herein include distributed hardware vulnerability identification and resolution. One method embodiment includes conducting an inventory of devices on a network and generating a queue of scanning jobs for each inventoried device to discover possible modes of network entry via each device. The method then proceeds by scanning devices on the network that are to be blocked according to a stored representation of an expected configuration of each device to identify devices of interest and queuing a new job for a deep scan of each device of interest. Each deep scan is executed to search one or both of a greater portion and in greater detail of a device of interest than prior scanning. The method then passes deep scan results to an incident manager to open an incident ticket for each device of interest.Type: ApplicationFiled: June 14, 2022Publication date: December 14, 2023Inventors: Riley Joseph MCKENNA, Kevin Matthew MARTIN, Kristopher Michael THOMAS
-
Publication number: 20230295517Abstract: A process for synthesising hydrocarbons is described comprising the steps of (a) making a synthesis gas comprising hydrogen, carbon monoxide and carbon dioxide from a feedstock in a synthesis gas generation unit, (b) removing carbon dioxide to produce a carbon dioxide stream and purified synthesis gas comprising hydrogen and carbon monoxide for synthesis gas in a Fischer-Tropsch hydrocarbon synthesis unit wherein (i) at least a portion of the FT water stream is fed to an electrolysis unit to provide an oxygen stream, which is fed to the synthesis gas generation unit. Carbon dioxide stream recovered from the carbon dioxide removal unit and a portion of the hydrogen stream produced by the electrolysis unit are fed to a reverse water-gas shift unit to produce a carbon monoxide stream, with carbon monoxide stream from the reverse water-gas shift unit fed to the Fischer-Tropsch hydrocarbon synthesis unit.Type: ApplicationFiled: September 17, 2021Publication date: September 21, 2023Inventors: Henry Arthur CLAXTON, Andrew James COE, Mark Joseph MCKENNA, Paul Robert TICEHURST
-
Publication number: 20230264955Abstract: A process for producing a gas stream comprising carbon monoxide comprising the steps of (a) feeding a gas mixture comprising carbon dioxide and hydrogen to a burner and combusting it with a sub-stoichiometric amount of an oxygen gas stream to form a combusted gas mixture comprising carbon monoxide, carbon dioxide, hydrogen and steam, (b) passing the combusted gas mixture through a bed of reverse water-gas shift catalyst to form a crude product gas mixture containing carbon monoxide, steam, hydrogen and carbon dioxide, (c) cooling the crude product gas mixture to below the dew point and recovering a condensate to form a dewatered product gas, (d) removing carbon dioxide from the dewatered product gas in a carbon dioxide removal unit to form the gas stream comprising carbon monoxide, and (e) combining carbon dioxide recovered by the carbon dioxide removal unit with the gas mixture comprising hydrogen and carbon dioxide.Type: ApplicationFiled: September 17, 2021Publication date: August 24, 2023Inventors: Henry Arthur CLAXTON, Amelia Lorna Solveig COOK, Mark Joseph MCKENNA
-
Publication number: 20230174377Abstract: A process of hydrogen production comprising the steps of: subjecting a gaseous mixture comprising a hydrocarbon and steam, and having a steam to carbon ratio of at least 0.9:1, to adiabatic pre-reforming in a pre-reformer followed by autothermal reforming with an oxygen-rich gas in an autothermal reformer to generate a reformed gas mixture, optionally adding steam to the reformed gas mixture, increasing the hydrogen content of the reformed gas mixture by subjecting it to one or more water-gas shift stages in a water-gas shift unit to provide a hydrogen-enriched reformed gas, cooling the hydrogen-enriched reformed gas and separating condensed water therefrom, passing the resulting de-watered hydrogen-enriched reformed gas to a carbon dioxide separation unit to provide a carbon dioxide gas stream and a crude hydrogen gas stream, passing the crude hydrogen gas stream to a purification unit to provide a purified hydrogen gas and a fuel gas.Type: ApplicationFiled: June 4, 2021Publication date: June 8, 2023Inventors: William John COTTON, Mark Joseph MCKENNA, Majid SADEQZADEH BOROUJENI
-
Publication number: 20230174378Abstract: A process for the production of hydrogen comprising the steps of subjecting a gaseous mixture comprising a hydrocarbon and steam and having a steam to carbon ratio of at least 2.6:1, to steam reforming in a gas-heated reformer followed by autothermal reforming with an oxygen-rich gas in an autothermal reformer to generate a reformed gas mixture, increasing the hydrogen content of the reformed gas mixture by subjecting it to one or more water-gas shift stages in a water-gas shift unit to provide a hydrogen-enriched reformed gas, cooling the hydrogen-enriched reformed gas and separating condensed water therefrom, passing the resulting de-watered hydrogen-enriched reformed gas to a carbon dioxide separation unit to provide a carbon dioxide gas stream and a crude hydrogen gas stream, and passing the crude hydrogen gas stream to a purification unit to provide a purified hydrogen gas and a fuel gas.Type: ApplicationFiled: June 4, 2021Publication date: June 8, 2023Inventors: William John COTTON, Mark Joseph MCKENNA, Majid SADEQZADEH BOROUJENI
-
Publication number: 20210299100Abstract: The present invention provides a compound of formula (1) or a pharmaceutically acceptable salt thereof; a method for manufacturing said compound, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition comprising said compound.Type: ApplicationFiled: March 15, 2021Publication date: September 30, 2021Inventors: Vincent BORDAS, Cara BROCKLEHURST, Patrick CHENE, Zhongbo FEI, Pascal FURET, Vito GUAGNANO, Patricia IMBACH-WEESE, Joerg KALLEN, Mickael LE DOUGET, Jialiang LI, Wei LI, Edwige Liliane Jeanne LORTHIOIS, Joseph McKENNA, Bahaa SALEM, Tobias SCHMELZLE, Holger SELLNER, Nicolas SOLDERMANN, Markus VOEGTLE, Markus WARTMANN
-
Publication number: 20210085307Abstract: A self-supporting surgical retractor is provided for retracting soft tissue and anatomy at a spinal surgical site. The retractor includes a tubular base defining an upper rim and a lower rim and a working channel there between the upper and lower rims, in which the base and lower rim are sized and configured to be seated on adjacent vertebral bodies spanning an intervertebral space. At least two elongated legs are provided, each projecting from the upper rim and each including a fixation feature at a free end thereof. Each of the legs has a length sufficient for the fixation feature to be outside the body of a patient when the lower rim is seated on adjacent vertebral bodies of the patient. The retractor is formed of a radio-transparent or radio-lucent material.Type: ApplicationFiled: September 18, 2020Publication date: March 25, 2021Inventors: Nick Sandham, Eddie Hamilton, Jonathan Lloyd Arcos, Christopher Reah, John Sutcliffe, Patrick Joseph McKenna, Obi Agu
-
Patent number: 10642834Abstract: Selecting a join plan for a query containing a join and a union block includes determining whether to propose a join plan with the join pushed across the union block. A selection is made between a join plan in which the join is not pushed across the union block and any proposed join plan in which the join is pushed across the union block.Type: GrantFiled: March 30, 2017Date of Patent: May 5, 2020Assignee: Teradata US, Inc.Inventors: Ahmad Said Ghazal, William Joseph McKenna
-
Patent number: 10024187Abstract: A method is provided for determining an updated engine health factor of an aircraft engine. The method includes determining an engine health condition indicative of an engine health during operation of the aircraft engine. The method also includes determining a baseline engine power model for the aircraft engine and modifying the baseline engine power model using the determined engine condition. The method also determines an engine health factor based on a modified engine power model.Type: GrantFiled: October 28, 2015Date of Patent: July 17, 2018Assignee: General Electric CompanyInventors: Alvaro Jose Soares, Jr., David Joseph McKenna, Marta Katarzyna Asack
-
Publication number: 20160273379Abstract: A method is provided for determining an updated engine health factor of an aircraft engine. The method includes determining an engine health condition indicative of an engine health during operation of the aircraft engine. The method also includes determining a baseline engine power model for the aircraft engine and modifying the baseline engine power model using the determined engine condition. The method also determines an engine health factor based on a modified engine power model.Type: ApplicationFiled: October 28, 2015Publication date: September 22, 2016Inventors: Alvaro Jose Soares, JR., David Joseph McKenna, Marta Katarzyna Asack
-
Patent number: 9359381Abstract: The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof; and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.Type: GrantFiled: December 17, 2013Date of Patent: June 7, 2016Assignee: Novartis AGInventors: Mahbub Ahmed, Alexander Ashall-Kelly, Louisa Gueritz, Jeffrey McKenna, Joseph McKenna, Simon Mutton, Rakesh Parmar, Jon Shepherd, Paul Wright
-
Patent number: 9303035Abstract: The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof; and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.Type: GrantFiled: December 17, 2013Date of Patent: April 5, 2016Assignee: Novartis AGInventors: Mahbub Ahmed, Alexander Ashall-Kelly, Graham Charles Bloomfield, Louisa Gueritz, Jeffrey McKenna, Joseph McKenna, Simon Mutton, Rakesh Parmar, Jon Sheperd, Paul Wright
-
Publication number: 20150336986Abstract: The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof; and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.Type: ApplicationFiled: December 17, 2013Publication date: November 26, 2015Applicant: Novartis AGInventors: Mahbub AHMED, Alexander ASHALL-KELLY, Louisa GUERITZ, Jeffrey MCKENNA, Joseph MCKENNA, Simon MUTTON, Rakesh PARMAR, Jon SHEPHERD, Paul WRIGHT
-
Patent number: 9067896Abstract: The present technology provides novel anhydrous and hydrated crystalline forms of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea, amorphous and anhydrous crystalline polymorphs of its monophosphoric acid salt, and the hydrochloride salt, including its dihydrate. The present technology further provides methods for preparing the various forms, compositions containing them, and methods of treatment employing them.Type: GrantFiled: December 6, 2010Date of Patent: June 30, 2015Assignee: Novartis AGInventors: Joerg Berghausen, Prasad K Kapa, Joseph McKenna, Joel Slade, Raeann Wu, Zhengming Du, Frank Stowasswer
-
Patent number: 8992640Abstract: The disclosed embodiments include systems for using an expander. In a first embodiment, a system includes a flow path and a gasification section disposed along the flow path. The gasification section is configured to convert a feedstock into a syngas. The system also includes a scrubber disposed directly downstream of the gasification section and configured to filter the syngas. The system also includes a first expander disposed along the flow path directly downstream from the scrubber and configured to expand the syngas. The syngas comprises an untreated syngas.Type: GrantFiled: February 7, 2011Date of Patent: March 31, 2015Assignee: General Electric CompanyInventors: Khodaram Rustom Khosravian, Ronald Frederick Tyree, Patrick Joseph McKenna
-
Patent number: 8946416Abstract: The present invention provides a new method of making compounds of formula (I): wherein R1 is mono- or polysubstituted aryl; R2 is hydrogen, lower alkyl or aryl; and R4 is hydrogen, lower alkyl or halogen.Type: GrantFiled: January 19, 2012Date of Patent: February 3, 2015Assignee: Novartis AGInventors: Wen-Chung Shieh, Joseph McKenna
-
Publication number: 20140171417Abstract: The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof; and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.Type: ApplicationFiled: December 17, 2013Publication date: June 19, 2014Applicant: NOVARTIS AGInventors: Mahbub AHMED, Alexander ASHALL-KELLY, Louisa GUERITZ, Jeffrey MCKENNA, Joseph MCKENNA, Simon MUTTON, Rakesh PARMAR, Jon SHEPHERD, Paul WRIGHT
-
Publication number: 20140171412Abstract: The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof; and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.Type: ApplicationFiled: December 17, 2013Publication date: June 19, 2014Applicant: NOVARTIS AGInventors: Mahbub AHMED, Alexander ASHALL-KELLY, Graham Charles BLOOMFIELD, Louisa GUERITZ, Jeffrey MCKENNA, Joseph MCKENNA, Simon MUTTON, Rakesh PARMAR, Jon SHEPERD, Paul WRIGHT